Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COR388 HCl placebo-controlled phase 2 trial in Alzheimer's disease
NL-OMON54863Phase 2Completed
- Sponsor
- IRulya Therapeutics
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atuzaginstat in Alzheimer's disease (AD), sponsored by IRulya Therapeutics. Started Nov 2019; status: completed.
02
Drugs
atuzaginstat
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON54863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54863.